Barry Paul

8PUBLICATIONS
33CO-AUTHORS
Medical biotechnology diagnostics (incl. biosensors)Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsMedical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Mar 14, 2026
A Real-World Analysis of the Safety and Efficacy of Teclistamab for Patients with Relapsed/Refractory Multiple Myeloma and Baseline Renal Impairment-USMIRC Group.

Maha Hameed, Alma Habib, Abdullah Mohammad Khan

|Feb 26, 2026
BCMA-Directed CAR T-Cell Therapy in Patients with Relapsed/Refractory Multiple Myeloma and Renal Impairment.

Alma Habib, Nausheen Ahmed, Abdullah Mohammad Khan

|Dec 11, 2025
Comparison of Standard of Care with or Without a PD-1/PD-L-1 Inhibitor for the Treatment of Multiple Myeloma: A Systematic Review and Meta-Analysis of Phase II and III Randomized Controlled Trials.

Zain Alsaddi, Osama Younis, Ghena Khasawneh

|Jun 09, 2025
Final Results of a Phase 2 Multi-Arm Study of Magrolimab Combinations in Patients With Relapsed/Refractory Multiple Myeloma.

Barry Paul, Jiri Minarik, Francesca Cottini

|Apr 15, 2025
Enhancing risk stratification and treatment decision in multiple myeloma with SKY92 gene expression profiling in real-world data.

Noa Biran, Binod Dhakal, Ruben Niesvizky

|Sep 14, 2024
Comparative Meta-Analysis of Triplet vs. Quadruplet Induction Regimens in Newly Diagnosed, Treatment Naïve, Multiple Myeloma.

Barry Paul, Faiz Anwer, Shahzad Raza

Pageof 2

Frequent Collaborators

5 joint publications

Shebli Atrash

3 joint publications

Al-Ola Abdallah

3 joint publications

Zahra Mahmoudjafari

2 joint publications

Hira Shaikh